Overcoming Immunologic Tolerance to Melanoma: Targeting CTLA-4 with Tremelimumab (CP-675,206).
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 10, doi. 10.1634/theoncologist.13-S4-10
- By:
- Publication type:
- Article
Works matching IS 10837159 AND DT 2008 AND VI 13 AND IP 4
Results: 25
1
2
Overcoming Immunologic Tolerance to Melanoma: Targeting CTLA-4 with Ipilimumab (MDX-010).
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 16, doi. 10.1634/theoncologist.13-S4-16
- By:
- Publication type:
- Article
3
Introduction.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 1, doi. 10.1634/theoncologist.13-S4-1
- By:
- Publication type:
- Article
4
The Mechanism of Anti-CTLA-4 Activity and the Negative Regulation of T-Cell Activation.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 2, doi. 10.1634/theoncologist.13-S4-2
- By:
- Publication type:
- Article
5
Dexrazoxane (TOTECT): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
6
Utility of radiolabeled somatostatin receptor analogues for staging/restaging and treatment of somatostatin receptor-positive pediatric tumors.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
7
Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
8
Commentary: can circulating HER-2 extracellular domain predict response to trastuzumab in HER-2-negative breast cancer?
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
9
A Phase II Study of Gefitinib for Patients with Advanced HER-1 Expressing Synovial Sarcoma Refractory to Doxorubicin-Containing Regimens.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 467, doi. 10.1634/theoncologist.2008-0065
- By:
- Publication type:
- Article
10
Epidermal Growth Factor Receptor Expression and Mutational Analysis in Synovial Sarcomas and Malignant Peripheral Nerve Sheath Tumors.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 459, doi. 10.1634/theoncologist.2007-0166
- By:
- Publication type:
- Article
11
Histologic Alterations from Neoadjuvant Chemotherapy in High-Grade Extremity Soft Tissue Sarcoma: Clinicopathological Correlation.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 451, doi. 10.1634/theoncologist.2007-0220
- By:
- Publication type:
- Article
12
Dexrazoxane (Totect™): FDA Review and Approval for the Treatment of Accidental Extravasation Following Intravenous Anthracycline Chemotherapy.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 445, doi. 10.1634/theoncologist.2007-0247
- By:
- Publication type:
- Article
13
Commentary: CT Screening for Lung Cancer--Caveat Emptor.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 439, doi. 10.1634/theoncologist.2008-0027
- By:
- Publication type:
- Article
14
Commentary: Lung Cancer Screening--Progress or Peril.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 435, doi. 10.1634/theoncologist.2008-0068
- By:
- Publication type:
- Article
15
Therapy Options in Imatinib Failures.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 424, doi. 10.1634/theoncologist.2007-0170
- By:
- Publication type:
- Article
16
Systemic Therapy for Biliary Tract Cancers.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 415, doi. 10.1634/theoncologist.2007-0252
- By:
- Publication type:
- Article
17
Intraperitoneal Chemotherapy in Patients with Advanced Ovarian Cancer: The Con View.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 410, doi. 10.1634/theoncologist.2007-0224
- By:
- Publication type:
- Article
18
Intraperitoneal Chemotherapy for Women with Epithelial Ovarian Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 403, doi. 10.1634/theoncologist.2007-0058
- By:
- Publication type:
- Article
19
Chemotherapy in Elderly Patients with Colorectal Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 390, doi. 10.1634/theoncologist.2007-0043
- By:
- Publication type:
- Article
20
Utility of Radiolabeled Somatostatin Receptor Analogues for Staging/Restaging and Treatment of Somatostatin Receptor--Positive Pediatric Tumors.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 382, doi. 10.1634/theoncologist.2007-0175
- By:
- Publication type:
- Article
21
Targeted Therapies for the Treatment of Breast Cancer in the Post-trastuzumab Era.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 373, doi. 10.1634/theoncologist.2007-0173
- By:
- Publication type:
- Article
22
Commentary: Can Circulating HER-2 Extracellular Domain Predict Response to Trastuzumab in HER-2--Negative Breast Cancer?
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 370, doi. 10.1634/theoncologist.2008-0050
- By:
- Publication type:
- Article
23
Trastuzumab plus Paclitaxel or Docetaxel in HER-2--Negative/HER-2 ECD--Positive Anthracycline- and Taxane-Refractory Advanced Breast Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 361, doi. 10.1634/theoncologist.2007-0207
- By:
- Publication type:
- Article
24
Current Status of Prognostic Profiling in Breast Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 350, doi. 10.1634/theoncologist.2007-0216
- By:
- Publication type:
- Article
25
Smoke, then Fire: Lung Cancer Screening Studies Under Further Scrutiny.
- Published in:
- Oncologist, 2008, v. 13, n. 4, p. 348, doi. 10.1634/theoncologist.2008-0079
- By:
- Publication type:
- Article